文献速递胃肠外科围术期管理与 ERAS

胃旁路术后残胃腺癌风险与诊断延迟

Cancer in the Excluded Stomach After Gastric Bypass Surgery for Obesity.
PubMed 文献 · Ann Surg · 2026-02-20

基于丹麦、芬兰、瑞典的队列研究(109,097例减重手术,其中胃旁路82,394例)发现,胃旁路术后10–44年残胃非贲门腺癌风险升高(HR=4.0, 95%CI 1.2–13.7;SIR=2.5, 95%CI 1.4–5.0),但术后1–9年风险无显著增加。该组患者胃切除率似降低(OR=0.3, 95%CI 0.1–1.1),全因死亡率似升高(HR=1.9, 95%CI 0.9–3.8)。

要点

  • 胃旁路术后10年以上残胃非贲门腺癌风险升高,需长期监测。
  • 术后1–9年风险未显著增加,早期筛查重点可能不在此时段。
  • 残胃癌发生后胃切除率似降低、死亡率似升高,提示诊断延迟。

核心结论

  • 胃旁路术可能增加被排除胃内腺癌风险并延迟诊断,但该癌症仍罕见。

研究设计与样本

  • 基于丹麦、芬兰、瑞典人群的队列研究,纳入109,097例减重手术(胃旁路82,394例,其他减重手术26,703例),随访至44年。

主要发现

  • 共46例(0.04%)发生胃非贲门腺癌,其中胃旁路后30例,其他减重术后16例。
  • 胃旁路术后10–44年胃非贲门腺癌风险较其他减重手术升高(HR=4.0, 95%CI 1.2–13.7),较一般人群升高(SIR=2.5, 95%CI 1.4–5.0)。
  • 胃旁路术后1–9年风险无显著增加(HR=1.0, 95%CI 0.3–4.2;SIR=0.9, 95%CI 0.4–1.4)。
  • 非贲门腺癌患者中,胃旁路术后胃切除率似降低(OR=0.3, 95%CI 0.1–1.1),全因死亡率似升高(HR=1.9, 95%CI 0.9–3.8)。

临床怎么用

  • 对胃旁路术后10年以上患者,应关注残胃癌可能,必要时完善内镜评估。
  • 向胃旁路术后患者告知残胃癌风险及诊断延迟可能性,促进症状预警。

局限性

  • 残胃癌总体罕见,事件数少,部分估计值置信区间宽。
  • 观察性设计可能受混杂因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether gastric bypass surgery for obesity increases the risk of adenocarcinoma in the excluded stomach and delays adenocarcinoma diagnosis. BACKGROUND: Gastric bypass might increase adenocarcinoma risk through bile reflux and delay such diagnosis because of anatomical hurdles with endoscopic access. METHODS: This population-based cohort study included patients having undergone bariatric surgery in Denmark, Finland, or Sweden. Cancer risk after gastric bypass was compared with (1) other bariatric procedures using Cox regression, providing hazard ratios (HR) with 95% confidence intervals (CI), adjusted for confounders, and (2) the general population of similar age, sex, calendar year, and country by calculating standardized incidence ratios (SIR). Gastrectomy rates and all-cause mortality were compared between bariatric procedures using logistic regression, providing odds ratios (OR), and Cox regression providing HRs, respectively. RESULTS: During up to 44 years of follow-up of 109,097 bariatric surgeries (82,394 gastric bypasses; 26,703 other bariatric surgeries), 46 (0.04%; 30 after gastric bypass; 16 after other bariatric surgeries) patients developed gastric non-cardia adenocarcinoma. Compared to other bariatric surgeries and the general population, gastric bypass was associated with an increased risk of gastric non-cardia adenocarcinoma between 10-44 years after surgery (HR=4.0, 95%-CI 1.2-13.7; SIR=2.5, 95%-CI 1.4-5.0), but not within the first 1-9 years (HR=1.0, 95%-CI 0.3-4.2; SIR=0.9, 95%-CI 0.4-1.4). Among the non-cardia adenocarcinoma patients, the gastrectomy rate was seemingly decreased (OR=0.3, 95%-CI 0.1-1.1) and all-cause mortality increased (HR=1.9, 95%-CI 0.9-3.8) after gastric bypass. CONCLUSION: Gastric bypass might increase the risk of adenocarcinoma in the excluded stomach and delay the detection when such tumors occur. Yet, this cancer is still rare after gastric bypass.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Leijonmarck W, Santoni G, Holmberg D, et al. Cancer in the Excluded Stomach After Gastric Bypass Surgery for Obesity. Ann Surg. 2026. PMID: 41718443. doi:10.1097/SLA.0000000000007035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。